ProCE Banner Activity

Congress to Clinic: Continual Evolution of HER3-Targeting in NSCLC With Expert Perspectives on Clinical Advances and Practical Application

Slideset

Downloadable slides with a comprehensive review of the most recent data on HER3-targeted treatment strategies for patients with advanced NSCLC from a live event.

Released: November 17, 2023

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc.